Spectators experienced significantly elevated heart rates, equivalent to rates with vigorous exercise, while watching hockey games live or on TV, according to a new study in the Canadian Journal of Cardiology
The Montreal Heart Institute is proud to announce the opening of the very first electrophysiology laboratory (EP Lab) equipped with robotic and magnetic navigation and dedicated to congenital heart diseases in Canada. Congenital heart diseases are cardiac malformations that affect approximately 1% of all Canadians.
M. André Boulet, President, CEO and Chairman of Devonian Health Group Inc a pharmaceutical company based in Québec Canada and Benoit Chotard, President of Orletto Capital inc., are pleased to announce the appointment of Dr. Jean-Claude Tardif, CM, MD, FRCPC, FCCS, FACC, FAHA, FESC, FCAHS as Chairman of the Scientific Advisory Board ("SAB") of Devonian, which will serve as a strategic resource to Devonian as it advances its clinical program.
A Montreal Heart Institute (MHI) researcher has conducted a study to evaluate the relationship between hostility and acute stress-induced changes in inflammatory response. The results of this study are published in the scientific journal PLOS ONE.
The Montreal Heart Institute Leads Worldwide Study. The Dalcetrapib to be Studied in Genetically Distinct Patients with Acute Coronary Syndrome (ACS). Global Study to be Conducted at 1,000 Sites in 33 Countries.